Cardinal Health (CAH) Q1 FY2027 earnings: revenue $67.5 billion, up 5.5% on the year
Cardinal Health Inc. (CAH) reported revenue of $67.5 billion for Q1 FY2027, the quarter ended 30 September 2026, up 5.5% on the same quarter a year earlier. Net income was $554 million, up 23.1% on the year, and diluted earnings per share $2.38. The figures are the company's own, from the 10-Q it filed with the SEC on 5 November 2026.
Revenue
$67.5 billion
+5.5% on the year · +6.0% on the quarter
Q2 FY2025Q1 FY2027
Operating margin
1.1%
1.0% a year earlier
Q2 FY2025Q1 FY2027
Net income
$554 million
+23.1% on the year · +39.2% on the quarter
Q2 FY2025Q1 FY2027
Diluted EPS
$2.38
+26.6% on the year · +40.0% on the quarter
Q2 FY2025Q1 FY2027
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Guidance figures: 5 raised, 2 lowered.
Revenue and operating earnings grew: Revenue rose 5% to $67.5 billion. GAAP operating earnings rose 13% to $753 million, from $668 million a year earlier.
Non-GAAP EPS rose 28%: Non-GAAP diluted EPS rose 28% to $3.26. The company attributes the increase to higher non-GAAP operating earnings, a lower share count and a lower effective tax rate.
Pharma revenue and profit grew: Pharmaceutical and Specialty Solutions revenue rose 6% to $62.6 billion. Segment profit rose 17% to $783 million, driven by brand and specialty products and generics program performance.
$ million except per share. Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q1 FY2027
Q4 FY2026
Q1 FY2026
On the quarter
On the year
Last 8 quarters
Operating cash flow
1,398
1,692
973
-17.4%
+43.7%
Capital expenditure
157
264
108
-40.5%
+45.4%
Free cash flow
1,241
1,428
865
-13.1%
+43.5%
Free cash flow margin
1.8%
2.2%
1.4%
Cash from investing
-251
-281
-142
Cash from financing
-742
-490
-110
Depreciation and amortisation
247
241
233
+2.5%
+6.0%
Share-based compensation
109
58.0
93.0
+87.9%
+17.2%
Buybacks
500
350
375
+42.9%
+33.3%
Dividends paid
126
120
129
+5.0%
-2.3%
Dividend per share
$0.52
n/a
$0.51
+1.0%
Diluted shares, weighted
233m
235m
239m
-0.9%
-2.5%
Shares outstanding at period end
231m
233m
238m
-0.6%
-2.7%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q1 FY2027
Q4 FY2026
Q1 FY2026
On the quarter
On the year
Last 8 quarters
Shareholders' equity
-3,025
-2,883
-2,879
Non-controlling interest
159
159
148
0.0%
+7.4%
Debt
8,815
8,886
9,032
-0.8%
-2.4%
Operating lease liabilities
n/a
861
n/a
Finance lease liabilities
n/a
140
n/a
Other liabilities
53,595
50,136
48,927
+6.9%
+9.5%
Total liabilities and equity
59,544
57,299
55,228
+3.9%
+7.8%
Fixed assets
2,999
3,031
2,831
-1.1%
+5.9%
Goodwill
11,543
11,442
9,711
+0.9%
+18.9%
Intangible assets
2,146
2,189
2,399
-2.0%
-10.5%
Cash and equivalents
5,264
4,856
4,593
+8.4%
+14.6%
Receivables
14,542
13,815
13,770
+5.3%
+5.6%
Inventory
18,395
17,297
17,559
+6.3%
+4.8%
Other assets
4,655
4,669
4,365
-0.3%
+6.6%
Total assets
59,544
57,299
55,228
+3.9%
+7.8%
Questions
What was Cardinal Health's revenue in Q1 FY2027?
Cardinal Health (CAH) reported revenue of $67.5 billion for Q1 FY2027, the quarter ended 30 September 2026, up 5.5% on the same quarter a year earlier.
How much did Cardinal Health earn in Q1 FY2027?
Net income for Q1 FY2027 was $554 million, up 23.1% on the year, and diluted earnings per share $2.38.
When did Cardinal Health report Q1 FY2027 results?
Cardinal Health filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 5 November 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 30 September 2026, filed 5 November 2026: the filing.